Abstract
The amelioration of drug prescribing practices holds out the prospect of improving health outcomes without increasing health care spending or the demands on hospital and ambulatory services. The challenge is to permit prescribers to assert their leadership as patient advocates while addressing the need for greater support in therapeutic decision making. Best practice includes the optimal use of drug and nondrug therapies and must be supported by research and the timely dissemination of information. The individualization of drug therapy will remain critical to quality prescribing and will depend on the appropriate preparation of prescribers for clinical decision making. The principal issues in improving prescribing practices were addressed at a workshop held by the CMA in Ottawa in October 1995, documents from which will be published in CMAJ, beginning with this issue (see pages 635 to 640). These issues deserve consideration by everyone with a stake in both cost-effectiveness and quality of care.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bradlow J., Coulter A. Effect of fundholding and indicative prescribing schemes on general practitioners' prescribing costs. BMJ. 1993 Nov 6;307(6913):1186–1189. doi: 10.1136/bmj.307.6913.1186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ellis J., Mulligan I., Rowe J., Sackett D. L. Inpatient general medicine is evidence based. A-Team, Nuffield Department of Clinical Medicine. Lancet. 1995 Aug 12;346(8972):407–410. [PubMed] [Google Scholar]
- Evidence-Based Medicine Working Group Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA. 1992 Nov 4;268(17):2420–2425. doi: 10.1001/jama.1992.03490170092032. [DOI] [PubMed] [Google Scholar]
- Hellman S. The patient and the public good. Nat Med. 1995 May;1(5):400–402. doi: 10.1038/nm0595-400. [DOI] [PubMed] [Google Scholar]
- Henke K. D., Murray M. A., Ade C. Global budgeting in Germany: lessons for the United States. Health Aff (Millwood) 1994 Fall;13(4):7–21. doi: 10.1377/hlthaff.13.4.7. [DOI] [PubMed] [Google Scholar]
- Soumerai S. B., Ross-Degnan D., Avorn J., McLaughlin T. j., Choodnovskiy I. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med. 1991 Oct 10;325(15):1072–1077. doi: 10.1056/NEJM199110103251505. [DOI] [PubMed] [Google Scholar]